JPH0524134B2 - - Google Patents

Info

Publication number
JPH0524134B2
JPH0524134B2 JP58125363A JP12536383A JPH0524134B2 JP H0524134 B2 JPH0524134 B2 JP H0524134B2 JP 58125363 A JP58125363 A JP 58125363A JP 12536383 A JP12536383 A JP 12536383A JP H0524134 B2 JPH0524134 B2 JP H0524134B2
Authority
JP
Japan
Prior art keywords
papaverine
calcium
minutes
amine
effect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP58125363A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5962553A (ja
Inventor
Kuaadoro Gizetsupe
Kaan Jan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SAA INTERN SA
YAASON Srl
Original Assignee
SAA INTERN SA
YAASON Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SAA INTERN SA, YAASON Srl filed Critical SAA INTERN SA
Publication of JPS5962553A publication Critical patent/JPS5962553A/ja
Publication of JPH0524134B2 publication Critical patent/JPH0524134B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP58125363A 1982-07-09 1983-07-08 カルシウム拮抗作用を有する化合物を含有する心臓血管疾患及び脳循環障害の治療剤 Granted JPS5962553A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT22339/82A IT1218324B (it) 1982-07-09 1982-07-09 Composti ad attivita' calcio-antagonista,metodo per la loro preparazione e composizioni farmaceutiche
IT22339A/82 1982-07-09
IT20838A/83 1983-04-28

Publications (2)

Publication Number Publication Date
JPS5962553A JPS5962553A (ja) 1984-04-10
JPH0524134B2 true JPH0524134B2 (enFirst) 1993-04-06

Family

ID=11194896

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58125363A Granted JPS5962553A (ja) 1982-07-09 1983-07-08 カルシウム拮抗作用を有する化合物を含有する心臓血管疾患及び脳循環障害の治療剤

Country Status (4)

Country Link
JP (1) JPS5962553A (enFirst)
BE (1) BE897244A (enFirst)
IT (1) IT1218324B (enFirst)
ZA (1) ZA834975B (enFirst)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992020645A1 (en) * 1991-05-20 1992-11-26 Tsumura & Co. Phellodendrine analogs and allergy type iv suppressor containing the same as active ingredient

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3987200A (en) * 1972-04-12 1976-10-19 Eli Lilly And Company Method for increasing cardiac contractility

Also Published As

Publication number Publication date
JPS5962553A (ja) 1984-04-10
ZA834975B (en) 1984-03-28
BE897244A (nl) 1983-11-03
IT8222339A0 (it) 1982-07-09
IT1218324B (it) 1990-04-12

Similar Documents

Publication Publication Date Title
JP3301024B2 (ja) グリシンレセプター拮抗物質及びその用途
FR2729951A1 (fr) Nouveaux composes heterocycliques, procede pour leur preparation et compositions pharmaceutiques en contenant
FR2612187A1 (fr) Derives du thiazole actifs sur le systeme cholinergique, leur procede de preparation et compositions pharmaceutiques en contenant
UA44332C2 (uk) Похідні 2(1h)-хінолінону як антагоністи серотоніну, спосіб їх одержання (варіанти), медичний препарат та фармацевтична композиція на їх основі
FR2636628A1 (fr) Derives du thiadiazole-1,3,4, leur procede d'obtention et compositions pharmaceutiques en contenant
JP2021519787A (ja) ６−アミノイソキノリンのモノ酸塩及びその使用
JPS636058B2 (enFirst)
FR2809730A1 (fr) Derives de 1,4-diazabicyclo[3.2.2] nonanebenzoxazole, -benzothiazole et -benzimidazole, leur preparation et leur application therapeutique
EP0306408B1 (fr) Imidazo[1,2b]pyridazines, procédé pour leur préparation et compositions pharmaceutiques les contenant
PL140021B1 (en) Process for preparing novel derivatives of piperidinedione
FR2501506A1 (fr) Compositions pharmaceutiques a action anorexigene contenant des derives de la tetrahydropyridine
JPH02503670A (ja) １，２，３，４，１０，１４ｂ‐ヘキサヒドロジベンゾ〔ｃ，ｆ〕ピラジノ〔１，２‐ａ〕アゼピノ誘導体及び１０‐アザ，１０‐オキサ及び１０‐チア類似体
PT78491B (en) Process for the preparation of new 5-acyl-2-(1h)-pyridinones useful as cardiotonic agents
JPH0723387B2 (ja) ピペラジンカルボン酸、その製造方法およびそれを含有する医薬組成物
JPH01275585A (ja) ４，５，６，７―テトラハイドロイソチアゾロ〔４，５―ｃ〕ピリジン誘導体及び異性体
EP0382635B1 (fr) Utilisation de dérivés d'alkyl-5 pyridazine comme médicaments actifs sur le système cholinergique
US4956389A (en) Compounds having calcium blocking activity
JPS5962553A (ja) カルシウム拮抗作用を有する化合物を含有する心臓血管疾患及び脳循環障害の治療剤
FR2501682A1 (fr) Trifluoromethylphenylpyridines a activite anorexigene, un procede de preparation et compositions pharmaceutiques en contenant
EP0179076B1 (fr) Derives sulfures de l'hydantoine et compositions pharmaceutiques les contenant
CH629194A5 (fr) Amino aryl triazines-1,2,4 utilisables dans le traitement d'algies diverses.
HU218479B (hu) Biciklolaktámszármazékok alkalmazása anxiolitikus hatású gyógyászati készítmények előállítására
CH641775A5 (fr) N-(1-methyl 2-pyrrolidinyl methyl) 2,3-dimethoxy 5-methylsulfamoyl benzamide et ses derives, son procede de preparation et composition le renferment.
FR2558160A1 (fr) 3-alkoxy 2-(n-pyrrolidino)-n-pyrimidinyl ou -pyrazinyl propylamines, leur preparation et leur application en therapeutique
EP0430800B1 (fr) Nouvelles benzothiazolinones substituées, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent